Here, we showed that FBP1 translocated into the nucleus and bound to DNA (cytosine‐5)‐methyltransferase 1 (DNMT1) to modulate the sensitivity of pancreatic cancer cells to PARP inhibitors. This evidence concerns the gene FBP1 and pancreatic neoplasm.